274 GSK Annual Report 2017 Other statutory disclosures US law and regulation A number of provisions of US law and regulation apply to the they are responsible for establishing and maintaining internal company because our shares are quoted on the New York Stock control over financial reporting that provides reasonable assurance Exchange NYSE in the form of ADS.
regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with NYSE rules generally accepted accounting principles In general, the NYSE rules permit the company to follow UK corporate governance practices instead of those applied in the US, they have disclosed in the annual report on Form 20-F any provided that we explain any significant variations.
This explanation changes in internal controls over financial reporting during the is contained in our Form 20-F, which can be accessed from the period covered by the annual report on Form 20-F that have Securities and Exchange Commissions SEC EDGAR database or materially affected, or are reasonably likely to affect materially, the via our website.
NYSE rules that came into effect in 2005 require us companys internal control over financial reporting, and they have to file annual and interim written affirmations concerning the Audit & disclosed, based on their most recent evaluation of internal control Risk Committee and our statement on significant differences in over financial reporting, to the external auditors and the ARC, all corporate governance.
significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are Sarbanes-Oxley Act of 2002 reasonably likely to affect adversely the companys ability to record, Following a number of corporate and accounting scandals in the US, process, summarise and report financial information, and any fraud Congress passed the Sarbanes-Oxley Act of 2002.
Sarbanes-Oxley regardless of materiality involving persons that have a significant is a wide-ranging piece of legislation concerned largely with financial role in the companys internal control over financial reporting.
The Group has carried out an evaluation under the supervision and As recommended by the SEC, the company has established a with the participation of its management, including the CEO and Disclosure Committee.
The Committee reports to the CEO, the CFO, of the effectiveness of the design and operation of the Groups CFO and to the Audit & Risk Committee ARC.
It is chaired by the disclosure controls and procedures as at 31 December 2017.
Company Secretary and the members consist of senior managers from finance, legal, corporate communications and investor relations.
There are inherent limitations to the effectiveness of any system of disclosure controls and procedures, including the possibility External legal counsel, the external auditors and internal experts of human error and the circumvention or overriding of the controls are invited to attend its meetings periodically.
It has responsibility and procedures.
Accordingly, even effective disclosure controls for considering the materiality of information and, on a timely basis, and procedures can only provide reasonable assurance of achieving determining the disclosure of that information.
It has responsibility their control objectives.
for the timely filing of reports with the SEC and the formal review of the Annual Report and Form 20-F.
In 2017, the Committee met The CEO and CFO expect to complete these certifications and 18 times.
report their conclusions on the effectiveness of disclosure controls and procedures in March 2018, following which the certificates Sarbanes-Oxley requires that the annual report on Form 20-F will be filed with the SEC as part of our Groups Form 20-F. contain a statement as to whether a member of the ARC is an audit committee financial expert as defined by Sarbanes-Oxley.
Such Section 404: Managements annual report on internal control a statement for the relevant member of the ARC Judy Lewent is over financial reporting included in the Audit & Risk Committee report on page 96 and in her In accordance with the requirements of section 404 of Sarbanesbiography on page 85.
Additional disclosure requirements arise Oxley, the following report is provided by management in respect of under section 302 and section 404 of Sarbanes-Oxley in respect of the companys internal control over financial reporting as defined in disclosure controls and procedures and internal control over Rules 13a-15 f and 15d-15 f under the US Securities Exchange financial reporting.
Act of 1934, as amended the Exchange Act : Section 302: Corporate responsibility for financial reports management is responsible for establishing and maintaining Sarbanes-Oxley also introduced a requirement for the CEO and adequate internal control over financial reporting for the Group.
the CFO to complete formal certifications, confirming that: Internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting they have each reviewed the annual report on Form 20-F and the preparation of financial statements for external purposes based on their knowledge, the annual report on Form 20-F in accordance with IFRS contains no material misstatements or omissions management conducted an evaluation of the effectiveness of based on their knowledge, the financial statements and other internal control over financial reporting based on the framework, financial information fairly present, in all material respects, the Internal Control Integrated Framework 2013 issued by the financial condition, results of operations and cash flows as of Committee of Sponsoring Organisations of the Treadway the dates, and for the periods, presented in the annual report Commission COSO on Form 20-F there have been no changes in the Groups internal control over they are responsible for establishing and maintaining disclosure financial reporting during 2017 that have materially affected, or controls and procedures that ensure that material information is are reasonably likely to affect materially, the Groups internal made known to them, and have evaluated the effectiveness of control over financial reporting these controls and procedures as at the year-end, the results management has assessed the effectiveness of internal control of such evaluation being contained in the annual report on over financial reporting as at 31 December 2017 and its Form 20-F conclusion will be filed as part of the Groups Form 20-F, and 275 GSK Annual Report 2017 Strategic report Governance and remuneration Financial statements Investor information US law and regulation continued  LLP, which has audited the Because the Group does not regularly receive information regarding consolidated financial statements of the Group for the year the identity of its distributors downstream customers, it cannot ended 31 December 2017, has also assessed the effectiveness establish the proportion of gross revenue or sales potentially of the Groups internal control over financial reporting under attributable to entities affiliated with the Iranian government or parties Auditing Standard No.
5 of the Public Company Accounting sanctioned for disclosable activities.
As a result, the Group is Oversight Board United States.
Their audit report will be filed reporting the entire gross revenues 12 million and net profits with the Groups Form 20-F. 4 million from the Groups sales to Iran in 2017.
Section 13 r of the Exchange Act The Group is also aware that some hospitals or other medical Section 13 r of the Exchange Act Section 13 r requires issuers facilities in Lebanon may be affiliated with or controlled by Hezbollah, to make specific disclosure in their annual reports of certain types which is designated by the United States as a terrorist organisation.
of dealings with Iran, including transactions or dealings with Again, the Group does not deal directly with such facilities and sells government-owned entities, as well as dealings with entities through distributors.
The Group is also unable to identify with sanctioned for activities related to terrorism or proliferation of certainty the degree or nature of any affiliation of the end customers weapons of mass destruction, even when those activities are not with Hezbollah, and the Group is unable to establish the proportion prohibited by US law and do not involve US persons.
The Group of gross revenue or sales potentially attributable to reportable exports certain pharmaceutical, vaccine and consumer products entities.
As a result, the Group is reporting the entire gross revenues to Iran, via sales by non-US entities, to two privately held Iranian 48 million and net profits 25 million from the Groups sales to distributors.
We do not believe that any of the Groups direct dealings with In addition to Section 13 r, US law also generally restricts dealings Iran require specific disclosure under these requirements.
by US persons or persons which are subject to US jurisdiction with certain countries or territories that are subject to comprehensive The Group does not regularly receive information regarding the sanctions.
The Group does business, via non-US entities, in such identity of its distributors downstream customers in Iran, and jurisdictions targeted by sanctions laws, including Syria, Cuba, it is possible that these customers include entities, such as North Korea and Crimea.
While we believe the Group complies government-owned hospitals and pharmacies, that are owned with all applicable US sanctions laws, such laws are complex and or controlled directly or indirectly by the Iranian government or continue to evolve rapidly.
by persons or entities sanctioned in connection with terrorism or proliferation activities.
Donations to political organisations and political expenditure With effect from 1 January 2009, to ensure a consistent approach Notwithstanding our policy, the Companies Act 2006 requires to political contributions across the Group, we introduced a global companies to continue to obtain shareholder approval before they policy to stop voluntarily all corporate political contributions.
can make donations to EU political organisations or incur EU political expenditure.
Therefore, while we do not make and do not intend to In the period from 1 January 2009 to 31 December 2017, the Group make donations to any EU political parties or organisations nor do did not make any political donations to EU or non-EU organisations.
we incur any EU political expenditure, the definitions of political Notwithstanding the introduction of this policy, in accordance with donations, political expenditure and political organisations used the Federal Election Campaign Act in the US, we continue to in the legislation are so wide that we annually seek shareholder support an employee-operated Political Action Committee PAC authorisation for any inadvertent expenditure.
In particular, the that facilitates voluntary political donations by eligible GSK definition of EU political organisations may extend to bodies such employees.
as those concerned with policy review, law reform, the representation of the business community and special interest groups such as The PAC is not controlled by GSK.
Decisions on the amounts and those concerned with the environment, which the company and its recipients of contributions are made by participating employees subsidiaries might wish to support.
As a result, the definitions may exercising their legal right to pool their resources and make political cover legitimate business activities not in the ordinary sense contributions, which are subject to strict limitations.
In 2017, a total considered to be political donations or political expenditure.
of US$ 384,875 2016 US$ 380,360 was donated to political organisations by the GSK employee PAC.
Such activities are not designed to support any political party or independent election candidate.
The authority which the Board has sought annually is a precautionary measure to ensure that the company and its subsidiaries do not inadvertently breach the legislation.
This authorisation process, for expenditure of up to 100,000 each year, dates back to the AGM held in May 2001, following the introduction of the Political Parties, Elections and Referendums Act 2000.
The authority has since been renewed annually.
276 GSK Annual Report 2017 Other statutory disclosures continued Group companies In accordance with Section 409 of the Companies Act 2006 a full list of subsidiaries, associates, joint ventures and joint arrangements, the address of the registered office and effective percentage of equity owned, as at 31 December 2017 are disclosed below.
Unless otherwise stated the share capital disclosed comprises ordinary shares which are indirectly held by GlaxoSmithKline plc.
The percentage held by class of share is stated where this is less than 100%.
Unless otherwise stated, all subsidiary companies have their registered office in their country of incorporation.
All subsidiary companies are resident for tax purposes in their country of incorporation unless otherwise stated.
Name Security Registered address Wholly owned subsidiaries 1506369 Alberta ULC Common 3500 855-2nd Street SW, Calgary, AB, T2P 4J8, Canada Action Potential Venture Capital Limited Ordinary 980 Great West Road, Brentford, Middlesex, TW8 9GS, England Adechsa GmbH Ordinary c o PRV Provides Treuhandgesellschaft AG, Dorfstrasse 38, Baar, 6341, Switzerland Affymax Research Institute Common Corporation Service Company, 2710 Gateway Oaks Drive, Suite 150N, Sacramento, California, CA, 95833, United States Alenfarma Especialidades Farmaceuticas, Limitada iv Ordinary Quota Rua Dr Antonio Loureiro Borges No 3, Arquiparque, Miraflores, Alges, 1499-013, Portugal Allen & Hanburys Limited iv Ordinary 980 Great West Road, Brentford, Middlesex, TW8 9GS, England Allen & Hanburys Pharmaceutical Nigeria Limited Ordinary 24 Abimbola Way, Ilasamaja, Isolo, Lagos, Nigeria Allen Farmaceutica, S. A.
Ordinary Severo Ochoa, 2, Parque Tecnologico fide Madrid, Tres Cantos, Madrid, 28760, Spain Allen Pharmazeutika Gesellschaft m. b. H. Ordinary Wagenseilgasse 3, Euro Plaza, Gebude I, 4.
Stock, Vienna, A-1120, Austria Barrier Therapeutics, Inc. Common Corporation Service Company, 251 Little Falls Drive, Wilmington, Delaware, 19808, United States Beecham Group p. l. c 20p Shares A: 5p Shares B 980 Great West Road, Brentford, Middlesex, TW8 9GS, England Beecham Pharmaceuticals Pte Limited Ordinary 38 Quality Road, Jurong Industrial Estate, Jurong, 618809, Singapore Beecham Pharmaceuticals S. A. iv vi Nominative Av 10 fide Agosto N36-239, y Naciones Unidas, Edificio Electroectuatoriana, 2do piso, Quito, Ecuador Beecham Portuguesa-Produtos Farmaceuticos e Quimicos, Lda, Ordinary Quota Rua Dr Antonio Loureiro Borges No 3, Arquiparque, Miraflores, Alges, 1499-013, Portugal Beecham S. A. iv vi Ordinary Parc fide la Noire Epine, rue Fleming 20, 1300 Wavre, Belgium Biddle Sawyer Limited Equity 252 Dr Annie Besant Road, Mumbai, 400030, India Biovesta Ilalari Ltd. Sti.
iv Nominative Bykdere Caddesi No.
Levent, Istanbul, 34394, Turkey Burroughs Wellcome & Co Australia Pty Limited in liquidation Ordinary 1061 Mountain Highway, Boronia, VIC, 3155, Australia Burroughs Wellcome & Co Bangladesh Limited Ordinary Fouzderhat Industrial Area, Dhaka Trunk Road, North Kattali, Chittagong 4217, Bangladesh Burroughs Wellcome International Limited Ordinary 980 Great West Road, Brentford, Middlesex, TW8 9GS, England Cascan GmbH & Co. KG Partnership Capital Industriestrasse 32-36, Bad Oldesloe, 23843, Germany Castleton Investment Ltd vi Ordinary C O DTOS, 19 Cybercity, 10th Floor Standard Chartered Tower, Ebene, Mauritius Cellzome GmbH Ordinary Meyerhofstrasse 1, Heidelberg, 69117, Germany Cellzome Limited Ordinary 980 Great West Road, Brentford, Middlesex, TW8 9GS, England Cellzome Therapeutics, Inc. iv Ordinary Corporation Service Company, 251 Little Falls Drive, Wilmington, Delaware, 19808, United States Cellzome, Inc.
Ordinary: Corporation Service Company, 251 Little Falls Drive, Wilmington, Series A Preferred: Delaware, 19808, United States Series B Preferred: Series C-1 Convertible Preferred: Series C-3 Convertible Preferred Charles Midgley Limited iv Ordinary: 7% Cumulative Preference 980 Great West Road, Brentford, Middlesex, TW8 9GS, England Chiron Behring Vaccines Private Limited Ordinary 401-402, A, Wing, 4th Floor, Floral Deck Plaza, Opp Rolta Bhavan, Central MIDC Road, Mumbai, Andheri E, 400093, India Clarges Pharmaceuticals Limited Ordinary: Preference 99.97% 980 Great West Road, Brentford, Middlesex, TW8 9GS, England Colleen Corporation Common with no par value Corporation Service Company, 251 Little Falls Drive, Wilmington, Delaware, 19808, United States Corixa Corporation Common Corporation Service Company, 251 Little Falls Drive, Wilmington, Delaware, 19808, United States Coulter Pharmaceutical, Inc. iv Common Corporation Service Company, 251 Little Falls Drive, Wilmington, Delaware, 19808, United States Dealcyber Limited Ordinary 980 Great West Road, Brentford, Middlesex, TW8 9GS, England Desarrollo Energia Solar Alternativa S. L. Ordinary Severo Ochoa, 2, Parque Tecnologico fide Madrid, Tres Cantos, Madrid, 28760, Spain 277 GSK Annual Report 2017 Strategic report Governance and remuneration Financial statements Investor information Group companies continued Name Security Registered address Wholly owned subsidiaries continued Domantis Limited Ordinary 980 Great West Road, Brentford, Middlesex, TW8 9GS, England Duncan Flockhart Australia Pty Limited iv vi Ordinary 1061 Mountain Highway, Boronia, VIC, 3155, Australia Edinburgh Pharmaceutical Industries Limited iv Ordinary: Preference Shewalton Road, Irvine, Ayrshire, KA11 5AP, Scotland Eskaylab Limited 10p Ordinary 980 Great West Road, Brentford, Middlesex, TW8 9GS, England Etex Farmacutica Limitada Social Capital Avenida Andres Bello 2687, Piso 19, Las Condes, Santiago, C. P. 7550611, Chile Fipar Thailand Ltd in liquidation Ordinary 12th Floor Wave Place, 55 Wireless Road, Lumpini, Pathumwan, Bangkok, 10330, Thailand Genelabs Technologies, Inc. Common Corporation Service Company, 2710 Gateway Oaks Drive, Suite 150N, Sacramento, California, 95833, United States Glaxo AS iv Ordinary Klaus Torgrds vei 3, Oslo, NO-0372, Norway Glaxo Group Limited Ordinary 980 Great West Road, Brentford, Middlesex, TW8 9GS, England Glaxo Kabushiki Kaisha iv Ordinary 1-8-1 Asasaka Minato-ku, Tokyo, Japan Glaxo Laboratories Nigeria Limited iv Ordinary 82 Marine Road, Apapa, Lagos, Nigeria Glaxo Laboratories Limited iv Ordinary 980 Great West Road, Brentford, Middlesex, TW8 9GS, England Glaxo New Zealand Pension Plan Trustee Limited Ordinary Level 11, Zurich House, 21 Queen Street, Auckland, 1010, New Zealand Glaxo Operations UK Limited Ordinary 980 Great West Road, Brentford, Middlesex, TW8 9GS, England Glaxo Properties BV Ordinary Huis ter Heideweg 62, 3705 LZ, Zeist, Netherlands Glaxo Verwaltungs GmbH Ordinary Industriestrasse 32-36, Bad Oldesloe, 23843, Germany Glaxo Wellcome Australia Pty Ltd iv vi Ordinary 1061 Mountain Highway, Boronia, VIC, 3155, Australia Glaxo Wellcome Farmaceutica, Limitada Ordinary Quota Rua Dr Antonio Loureiro Borges No 3, Arquiparque, Miraflores, Alges, 1499-013, Portugal Glaxo Wellcome International B. V. v Ordinary Huis ter Heideweg 62, 3705 LZ, Zeist, Netherlands Glaxo Wellcome Manufacturing Pte Ltd Ordinary 1 Pioneer Sector 1, Jurong Industrial Estate, Jurong, 628413, Singapore Glaxo Wellcome Production S. A. S. Ordinary 23 rue Franois Jacob, 92500, Rueil-Malmaison, France Glaxo Wellcome PST Pty Ltd in liquidation Ordinary 1061 Mountain Highway, Boronia, VIC, 3155, Australia Glaxo Wellcome UK Limited Ordinary 980 Great West Road, Brentford, Middlesex, TW8 9GS, England Glaxo Wellcome Vidhyasom Limited iv Ordinary 12th Floor Wave Place, 55 Wireless Road, Lumpini, Pathumwan, Bangkok, 10330, Thailand Glaxo Wellcome, S. A.
Ordinary Poligono Industrial Allendeduero, Avenida fide Extremadura, 3, Aranda fide Duero, Burgos, 09400, Spain Glaxo, S. A.
Ordinary Severo Ochoa, 2, Parque Tecnologico fide Madrid, Tres Cantos, Madrid, 28760, Spain Glaxo-Allenburys Nigeria Limited iv Ordinary 41 Creek Road, Apapa, Lagos, PMB 1401, Nigeria Glaxochem UK Unlimited Ordinary: 980 Great West Road, Brentford, Middlesex, TW8 9GS, England Ordinary B: Ordinary C Glaxochem Pte Ltd v Ordinary 23 Rochester Park, 139234, Singapore GlaxoSmithKline Produtos Farmaceuticos, Limitada Ordinary Quota Rua Dr Antonio Loureiro Borges No 3, Arquiparque, Miraflores, Alges, 1499-013, Portugal GlaxoSmithKline Cambodia Co. Ltd.
Ordinary 5th Floor DKSH Building, No.
797 Preah Monivong Boulevard Corner of Street 484, Sangkat Phsar Deum Thakov, Khan Chamkarmon, Phnom Penh, Cambodia GlaxoSmithKline China Investment Co Ltd Ordinary Room 901 910, Building A, Ocean International Center, 56 Mid 4th East Ring Road, Bejing, Chaoyang District, China GlaxoSmithKline China R&D Company Limited Equity No 3 Building, 898 Halei Road, Zhang Jiang, Hi Tech Park Pudong New Area, Shanghai, China GlaxoSmithKline Cyprus Limited Ordinary Arch.
Makariou III, 2-4, Capital Center, 9th Floor, Nicosia, P. C. 1065, Cyprus GlaxoSmithKline GSK S. R. L. Ordinary 1-5 Costache Negri Street, Opera Center One, 5th and 6th floors, Zone 1, District 5, Bucharest, Romania GlaxoSmithKline Ireland Limited ii Ordinary 12 Riverwalk Citywest Business Campus, Dublin, 24, Ireland GlaxoSmithKline Israel Ltd Ordinary 25 Basel Street, PO Box 10283, Petach-Tikva, 49002, Israel GlaxoSmithKline Malta Limited Ordinary 1, First Floor, fide La Cruz Avenue, Qormi, QRM2458, Malta GlaxoSmithKline Private Limited iv Ordinary Unit 3, 20 Anthony Road, Msasa, Harare, Zimbabwe GlaxoSmithKline Thailand Limited Ordinary 12th Floor Wave Place, 55 Wireless Road, Lumpini, Pathumwan, Bangkok, 10330, Thailand GlaxoSmithKline A. E. B. E. Ordinary 266 Kifissias Avenue, Halandri, Athens, 152 32, Greece GlaxoSmithKline AB Ordinary Hemvarnsg.
9, Solna, 171 54, Sweden GlaxoSmithKline AG Ordinary Talstrasse 3-5, 3053 Muenchenbuchsee, Switzerland GlaxoSmithKline Angola Unipessoal Limitada Quotas At Bollore Africa Logistics Angola, Estrada fide Cacuaco n 288, CP 2163, Bairro Petrangol, Luanda, Angola 278 GSK Annual Report 2017 Other statutory disclosures continued Group companies continued Name Security Registered address Wholly owned subsidiaries continued GlaxoSmithKline Argentina S. A.
Ordinary Tucumn 1, piso 4, Buenos Aires, C1049AAA, Argentina GlaxoSmithKline AS Ordinary Klaus Torgrds vei 3, Oslo, NO-0372, Norway GlaxoSmithKline Asia Pvt.
Limited Equity Patiala Road, Nabha 147201, Dist Patiala, Punjab, India GlaxoSmithKline Australia Pty Ltd Ordinary 1061 Mountain Highway, Boronia, VIC, 3155, Australia GlaxoSmithKline B. V. Ordinary Huis ter Heideweg 62, 3705 LZ, Zeist, Netherlands GlaxoSmithKline Beteiligungs GmbH Ordinary Prinzregentenplatz 9, Mnchen, 81675, Germany GlaxoSmithKline Biologicals Shanghai Ltd.
277 Niudun Road, Zhangjiang Hi-Teck Park, Shanghai, China GlaxoSmithKline Biologicals Kft.
Ordinary 2100 Gdll, Homoki Nagy Istvn utca 1, Hungary GlaxoSmithKline Biologicals S. A. S. Ordinary 637 Rue des Aulnois, Saint-Amand Les Eaux, 59230, France GlaxoSmithKline Biologicals SA Ordinary: Preference Rue fide l'Institut 89, B-1330 Rixensart, Belgium GlaxoSmithKline Brasil Limitada Quotas Estrada dos Banderiantes, 8464, Rio fide Janeiro, 22783-110, Brazil GlaxoSmithKline Capital Inc.
Ordinary Wilmington Trust SP Services Inc. 1105 North Market Street, Suite 1300, Wilmington, Delaware, 19801, United States GlaxoSmithKline Capital plc Ordinary 980 Great West Road, Brentford, Middlesex, TW8 9GS, England GlaxoSmithKline Caribbean Limited Ordinary 980 Great West Road, Brentford, Middlesex, TW8 9GS, England GlaxoSmithKline Chile Farmaceutica Limitada Social Capital Avenida Andres Bello No.
2687, Piso 19, Las Condes, Santiago, C. P. 7550611, Chile GlaxoSmithKline Colombia S. A.
Ordinary Avenida El Dorado, #69B-45 Piso 9, Bogota, Colombia GlaxoSmithKline Consumer Healthcare Investments Ireland Ordinary 6900 Cork Airport Business Park, Kinsale Road, Cork, County Cork, Limited ii iv v Ireland GlaxoSmithKline Consumer Healthcare Ireland IP Limited ii v Ordinary Currabinny, Carrigaline, County Cork, Ireland GlaxoSmithKline Consumer Holding B. V. iv Ordinary Huis ter Heideweg 62, 3705 LZ, Zeist, Netherlands GlaxoSmithKline d. o. o Quotas Zmja od Bosne broj 7-7a, Sarajevo, 71000, Bosnia and Herzegovina GlaxoSmithKline d. o. o.
Equity capital Ulica Damira Tomljanovica Gavrana 15, Zagreb, Croatia GlaxoSmithKline doo Beograd Ordinary Omladinskih brigada 88, New Belgrade, City of Belgrade, 11070, Serbia GlaxoSmithKline Ecuador S. A.
Ordinary Av 10 fide Agosto N36-239, y Naciones Unidas, Edificio Electroectuatoriana, 2do piso, Quito, Ecuador GlaxoSmithKline Eesti OU Ordinary Ltsa 8a, Tallinn, 11415, Estonia GlaxoSmithKline ehf iv vi Dissolved January 2018 Ordinary Thverholt 14, 105, Reykjavik, Iceland GlaxoSmithKline El Salvador S. A. fide C. V. Ordinary Avenida El Boqueron y Calle Izalco No 7 y 8 Parque Industrial El Boqueron, Santa Elen, Antiguo Custatlan, La Libertad, El Salvador GlaxoSmithKline EOOD Ordinary 115 G Tsarigradsko Shose Blvd.
floor 9, Mladost Region, Sofia, 1784, Bulgaria GlaxoSmithKline Export Limited Ordinary 980 Great West Road, Brentford, Middlesex, TW8 9GS, England GlaxoSmithKline Export Panama S. A.
Ordinary Panama City, Republic of Panama, Panama GlaxoSmithKline Far East B. V. Ordinary Huis ter Heideweg 62, 3705 LZ, Zeist, Netherlands GlaxoSmithKline Finance plc Ordinary 980 Great West Road, Brentford, Middlesex, TW8 9GS, England GlaxoSmithKline GmbH & Co. KG Partnership Capital Prinzregentenplatz 9, Mnchen, 81675, Germany GlaxoSmithKline Guatemala S. A.
Ordinary Novena Avenida 0-09, Zona 4, Guatemala City, Guatemala GlaxoSmithKline Holding AS Ordinary Klaus Torgrds vei 3, Oslo, NO-0372, Norway GlaxoSmithKline Holdings Americas Inc. Common with no par value Wilmington Trust SP Services Inc. 1105 North Market Street, Suite 1300, Wilmington, Delaware, 19801, United States GlaxoSmithKline Holdings Ireland Limited Ordinary: Deferred 980 Great West Road, Brentford, Middlesex, TW8 9GS, England GlaxoSmithKline Holdings One Limited i Ordinary 980 Great West Road, Brentford, Middlesex, TW8 9GS, England GlaxoSmithKline Holdings Limited i Ordinary 980 Great West Road, Brentford, Middlesex, TW8 9GS, England GlaxoSmithKline Holdings Pty Ltd Ordinary 1061 Mountain Highway, Boronia, VIC, 3155, Australia GlaxoSmithKline Honduras S. A.
Ordinary Tegucigalpa, MDC, Honduras GlaxoSmithKline IHC Limited Ordinary 980 Great West Road, Brentford, Middlesex, TW8 9GS, England GlaxoSmithKline Ilaclari Sanayi five Ticaret A. S. Nominative Bykdere Caddesi No.
Levent, Istanbul, 34394, Turkey GlaxoSmithKline Inc. Class A Common: Class C Preference 7333 Mississauga Road North, Mississauga, ON, L5N 6L4, Canada GlaxoSmithKline Insurance Ltd.
Ordinary 19 Par-La-Ville Road, Hamilton, HM11, Bermuda GlaxoSmithKline Intellectual Property No.
2 Limited Ordinary 980 Great West Road, Brentford, Middlesex, TW8 9GS, England GlaxoSmithKline Intellectual Property Development Limited Ordinary 980 Great West Road, Brentford, Middlesex, TW8 9GS, England GlaxoSmithKline Intellectual Property Holdings Limited A Ordinary: B Ordinary 980 Great West Road, Brentford, Middlesex, TW8 9GS, England GlaxoSmithKline Intellectual Property Limited Ordinary: Deferred 980 Great West Road, Brentford, Middlesex, TW8 9GS, England GlaxoSmithKline Intellectual Property Management Limited Ordinary 980 Great West Road, Brentford, Middlesex, TW8 9GS, England GlaxoSmithKline International Limited Ordinary 980 Great West Road, Brentford, Middlesex, TW8 9GS, England GlaxoSmithKline Investigacin y Desarrollo, S. L. Ordinary Severo Ochoa 2 Parque Tecnolgico fide Madrid, Tres Cantos, Madrid, 28760, Spain 279 GSK Annual Report 2017 Strategic report Governance and remuneration Financial statements Investor information Group companies continued Name Security Registered address Wholly owned subsidiaries continued GlaxoSmithKline Investment Holdings Limited Ordinary 980 Great West Road, Brentford, Middlesex, TW8 9GS, England GlaxoSmithKline Investment Services Limited Ordinary 980 Great West Road, Brentford, Middlesex, TW8 9GS, England GlaxoSmithKline Investments Ireland Limited ii v Ordinary Currabinny, Carrigaline, County Cork, Ireland GlaxoSmithKline Investments Pty Ltd Ordinary 1061 Mountain Highway, Boronia, VIC, 3155, Australia GlaxoSmithKline K. K. Ordinary 1-8-1 Asasaka Minato-ku, Tokyo, Japan GlaxoSmithKline Korea Limited Ordinary 9F LS Yongsan Tower 92, Hangangdae-ro Yongsan-gu, Seoul, 140-702, Republic of Korea GlaxoSmithKline Latin America, S. A.
Ordinary Panama City, Republic of Panama, Panama GlaxoSmithKline Latvia SIA Ordinary Duntes iela 3, Riga, Latvia GlaxoSmithKline Lietuva UAB Ordinary Ukmerges st. 120, Vilnius, LT-08105, Lithuania GlaxoSmithKline Limited Ordinary Units 2201, 2214 and 23 F, Tower 6, The Gateway, 9 Canton Road, Harbour City, Tsimshatsui, Kowloon, Hong Kong GlaxoSmithKline LLC LLC Interests Corporation Service Company, 251 Little Falls Drive, Wilmington, Delaware, 19808, United States GlaxoSmithKline Manufacturing SpA Ordinary Via Alessandro Fleming 2, Verona, 37135, Italy GlaxoSmithKline Maroc S. A.
Ordinary 42-44 Angle Bd, Rachidi et Abou Hamed El Glaza, Casablanca, Morocco GlaxoSmithKline Medical and Healthcare Products Limited Ordinary H-1124, Csorsz utca 43, Budapest, Hungary GlaxoSmithKline Mercury Limited i Ordinary 980 Great West Road, Brentford, Middlesex, TW8 9GS, England GlaxoSmithKline Mexico S. A. fide C. V. Ordinary Calzada, Mexico-Xochimilco 4900, Colonia San Lorenzo, Huipulco, Delegacion Tlalpan, 14370, Mexico GlaxoSmithKline NZ Limited Ordinary Level 11, Zurich House, 21 Queen Street, Auckland, 1010, New Zealand GlaxoSmithKline Oy Ordinary Piispansilta 9A, P. O.
Box 24, Espoo, FIN-02230, Finland GlaxoSmithKline Peru S. A.
Javier Prado Oeste, 995, San Isidro, LIMA 27, Peru GlaxoSmithKline Pharma A S Ordinary Nykaer 68, Brondby, DK-2605, Denmark GlaxoSmithKline Pharma GmbH Ordinary Wagenseilgasse 3, Euro Plaza, Gebude I, 4.
Stock, Vienna, A-1120, Austria GlaxoSmithKline Pharmaceutical Kenya Limited Ordinary L. R. NO.
209 6921, 5th Floor, Icea Lion Centre, Riverside Park West Wing, Chiromo Road, Westlands P. O.
Box 10643-00100, Nairobi, Kenya GlaxoSmithKline Pharmaceutical Nigeria Limited Ordinary 1 Industrial Avenue, Ilupeju, Ikeja, Lagos, PM B 21218, Nigeria GlaxoSmithKline Pharmaceutical Sdn Bhd Ordinary Level 6, Quill 9, 112, Jalan Semangat, Petaling Jaya, Selangor Darul Ehsan, 46300, Malaysia GlaxoSmithKline Pharmaceuticals Pvt Ltd Ordinary 121 Galle Road, Kaldemulla, Moratuwa, Sri Lanka GlaxoSmithKline Pharmaceuticals Suzhou Limited Ordinary No 40 Su Hong Xi Road, Suzhou Industrial Park, Suzhou, 215021, China GlaxoSmithKline Pharmaceuticals Costa Rica S. A Ordinary 300 metros al este fide la Rotonda fide la Betania, Mercedes fide Montes fide Oca, Sabanilla, Montes fide Oca, San Jose, Costa Rica GlaxoSmithKline Pharmaceuticals S. A.
Grunwaldzka 189, Poznan, 60-322, Poland Ordinary B: Ordinary C: Ordinary D GlaxoSmithKline Pharmaceuticals SA Ordinary Site Apollo, Avenue Pascal 2-4-6, Wavre, 1300, Belgium GlaxoSmithKline Pharmaceuticals Ukraine LLC Chartered Capital Pavla Tychyny avenue, 1-V, Kiev, 02152, Ukraine GlaxoSmithKline Pte Ltd Ordinary 23 Rochester Park, 139234, Singapore GlaxoSmithKline Puerto Rico Inc. Common Centro Internacional fide Mercadeo, 90 Road # 165, Tower II, Suite 800, Guaynabo, 00968, Puerto Rico GlaxoSmithKline Republica Dominicana S. A.
Ordinary Ave. Lope fide Vega #29, Torre NovoCentro, Local 406, Santo Domingo, Dominican Republic GlaxoSmithKline Research & Development Limited Ordinary 980 Great West Road, Brentford, Middlesex, TW8 9GS, England GlaxoSmithKline S. A.
Ordinary Severo Ochoa, 2, Parque Tecnologico fide Madrid, Tres Cantos, Madrid, 28760, Spain GlaxoSmithKline S. p. A.
Ordinary Via Alessandro Fleming 2, Verona, 37135, Italy GlaxoSmithKline s. r. o.
Ordinary Hvezdova 1734 2c, Prague, 4 140 00, Czech Republic GlaxoSmithKline Services GmbH & Co. KG Partnership Capital Prinzregentenplatz 9, Mnchen, 81675, Germany GlaxoSmithKline Services Inc. iv Common Corporation Service Company, 251 Little Falls Drive, Wilmington, Delaware, 19808, United States GlaxoSmithKline Services Unlimited i Ordinary 980 Great West Road, Brentford, Middlesex, TW8 9GS, England GlaxoSmithKline SL Holdings, LLC LLC Interests Corporation Service Company, 251 Little Falls Drive, Wilmington, Delaware, 19808, United States GlaxoSmithKline SL LLC LLC Interests Corporation Service Company, 251 Little Falls Drive, Wilmington, Delaware, 19808, United States GlaxoSmithKline SL LP iv Partnership 980 Great West Road, Brentford, Middlesex, TW8 9GS, England GlaxoSmithKline Slovakia s. r. o.
Ordinary Galvaniho 7 A, Bratislava, 821 04, Slovakia 280 GSK Annual Report 2017 Other statutory disclosures continued Group companies continued Name Security Registered address Wholly owned subsidiaries continued GlaxoSmithKline South Africa Pty Limited Ordinary Flushing Meadows Building, The Campus, 57 Sloane Street, Bryanston 2021, South Africa GlaxoSmithKline Superannuation Company Pty Ltd Ordinary 1061 Mountain Highway, Boronia, VIC, 3155, Australia in liquidation GlaxoSmithKline Trading Services Limited ii v Ordinary Currabinny, Carrigaline, County Cork, Ireland GlaxoSmithKline Trading ZAO Ordinary Yakimanskaya nab.
2, Moscow, 119180, Russian Federation GlaxoSmithKline Tunisia S. A. R. L. Ordinary Immeuble Les Quatres R, Rue du Lac Lochness, Berges du Lac, Tunis, Tunisia GlaxoSmithKline UK Limited Ordinary 980 Great West Road, Brentford, Middlesex, TW8 9GS, England GlaxoSmithKline Uruguay S. A.
Registered shares provisory stock Salto 1105, CP 11.200 Montevideo, Uruguay GlaxoSmithKline Venezuela C. A.
Ordinary Urbanizacion La Trinidad, Calle luis fide Camoems, Edif No 115-117 Apatado Posta, Caracas, 1010, Venezuela GlaxoSmithKline Vietnam Limited Liability Company iv vi Equity capital The Metropolitan, 235 Dong Khoi Street, District 1, 7th Floor Unit 701, Ho Chi Minh City, Viet Nam GlycoVaxyn AG vi Common: Preferred A: Grabenstrasse 3, 8952 Schlieren, Switzerland Preferred B: Preferred C Group Laboratories South Africa Pty Limited iv vi Ordinary Flushing Meadows Building, The Campus, 57 Sloane Street, Bryanston 2021, South Africa Groupe GlaxoSmithKline S. A. S. Ordinary 23 rue Franois Jacob, 92500, Rueil-Malmaison, France GSK Business Service Centre Sdn Bhd Ordinary Level 6, Quill 9, 112, Jalan Semangat, Petaling Jaya, Selangor Darul Ehsan, 46300, Malaysia GSK Capital K. K. Ordinary 1-8-1 Asasaka Minato-ku, Tokyo, Japan GSK CH Argentina S. A. Nominative non endorseable ordinary shares Tucumn 1, piso 4, Buenos Aires, C1049AAA, Argentina GSK Commercial Sp.
Rzymowskiego 53, Warsaw, 02-697, Poland GSK d. o. o. Ljubljana Ordinary Amerika ulica 8, Ljubljana, 1000, Slovenia GSK Kazakhstan LLP Charter Capital 273, Furmanov Street, Almaty, Medeu District, 050059, Kazakhstan GSK Pharmaceutical Trading SA Ordinary 5 Poienelor Street, Brasov, Romania GSK Services Sp z o. o.
Grunwaldzka 189, Poznan, 60-322, Poland GSK Vaccines BV iv Ordinary Hullenbergweg 85, Amsterdam, 1101 CL, Netherlands GSK Vaccines GmbH Ordinary Emil-von-Behring-Str.
76, 35041 Marburg, Germany GSK Vaccines Institute for Global Health S. r. l. Quotas Via Fiorentina 1, Siena, 53100, Italy GSK Vaccines S. r. l. Quotas Via Fiorentina 1, Siena, 53100, Italy GSK Vaccines Vertriebs GmbH Ordinary Rudolf-Diesel-Ring 27, Holzkirchen, 83607, Germany HGS France S. a. r. l. iv vi Ordinary 52-54 rue fide la Belle Feuille, Boulogne-Billancourt, 92100, France Horlicks Limited Ordinary 980 Great West Road, Brentford, Middlesex, TW8 9GS, England Human Genome Sciences Pacific Pty Ltd in liquidation Ordinary 1061 Mountain Highway, Boronia, VIC, 3155, Australia Human Genome Sciences, Inc. Common Corporation Service Company, 251 Little Falls Drive, Wilmington, Delaware, 19808, United States ID Biomedical Corporation of Quebec Common 2323 du Parc Technologique, Qubec, PQ, G1P 4R8, Canada ID Biomedical Corporation of Washington iv Common Corporation Service Company, 251 Little Falls Drive, Wilmington, Delaware, 19808, United States Instituto Luso Farmaco, Limitada iv Quotas Rua Dr Antonio Loureiro Borges No 3, Arquiparque, Miraflores, Alges, 1499-013, Portugal InterPharma Dienstleistungen GmbH Quotas Wagenseilgasse 3, Euro Plaza, Gebude I, 4.
Stock, Vienna, A-1120, Austria J&J Technologies, LC iv LLC Interests Corporation Service Company, 100 Shockoe Slip, 2nd Floor, Richmond, VA 23219, United States Laboratoire GlaxoSmithKline Ordinary 23 rue Franois Jacob, 92500, Rueil-Malmaison, France Laboratoire Pharmaceutique Algrien LPA Production SPA Ordinary Zone Industrielle Est, Boudouaou, Boumerdes, Algeria Laboratoire Pharmaceutique Algrien SPA Ordinary Zone Industrielle Est, Boudouaou, Boumerdes, Algeria Laboratoires Paucourt iv Ordianry 23 rue Franois Jacob, 92500, Rueil-Malmaison, France Laboratoires Saint-Germain iv Ordianry 23 rue Franois Jacob, 92500, Rueil-Malmaison, France Laboratorios Dermatologicos Darier, S. A fide C. V. Ordianry Calzada Mexico Xochimilco, 4900 San Lorenzo Huipulco, District Federal Mexico, 14370, Mexico Laboratorios Farmaceuticos Stiefel Portugal LTDA iv Ordinary Rua Dr Antonio Loureiro Borges No 3, Arquiparque, Miraflores, Alges, 1499-013, Portugal Laboratorios Stiefel fide Chile & Compaa Limitada vi Social Capital Avenida Andres Bello 2687, Piso 19, Las Condes, Santiago, C. P. 7550611, Chile Laboratorios Stiefel fide Venezuela SA vi Ordinary Urbanizacion La Trinidad, Calle luis fide Camoems, Edif No 115-117 Apatado Posta, Caracas, 1010, Venezuela Laboratorios Stiefel Ltda.
Ordinary Rua Professor Joao C Salem 1081 1301, Guarulhos, Sao Paulo, Brazil 281 GSK Annual Report 2017 Strategic report Governance and remuneration Financial statements Investor information Group companies continued Name Security Registered address Wholly owned subsidiaries continued Laboratorios Wellcome fide Portugal Limitada iv Ordinary Quota Rua Dr Antonio Loureiro Borges No 3, Arquiparque, Miraflores, Alges, 1499-013, Portugal Maxinutrition Limited in liquidation Ordinary 55 Baker Street, London, W1U 7EU, England Mixis Genetics Limited Ordinary: Ordinary Euro 980 Great West Road, Brentford, Middlesex, TW8 9GS, England Montrose Fine Chemical Company Ltd Ordinary Shewalton Road, Irvine, Ayrshire, KA11 5AP, Scotland Montrose Pharma Company Limited iv vi Ordinary Quota H-1124, Csorsz utca 43, Budapest, Hungary Novartis Vaccines and Diagnostics AG in liquidation Ordinary c o OBC Suisse AG, Aeschenvorstadt 71, Basel, 4051, Switzerland Novartis Vaccines and Diagnostics Pty Ltd iv vi Ordinary 1061 Mountain Highway, Boronia, VIC, 3155, Australia Okairos AG in liquidation Common: c o OBC Suisse AG, Aeschenvorstadt 71, 4051, Basel, Switzerland Preferred A: Preferred B Penn Labs Inc. iv Common Corporation Service Company, 251 Little Falls Drive, Wilmington, Delaware, 19808, United States S. R. One International B. V. Ordinary Huis ter Heideweg 62, 3705 LZ, Zeist, Netherlands S. R. One, Limited Units Common Corporation Service Company, 2595 Interstate Drive, Suite 103, Harrisburg, Pennsylvania, 17110, United States Setfirst Limited Ordinary 980 Great West Road, Brentford, Middlesex, TW8 9GS, England Smith Kline & French Laboratories Limited Ordinary 980 Great West Road, Brentford, Middlesex, TW8 9GS, England Smith Kline & French Portuguesa-Produtos Ordinary Rua Dr Antonio Loureiro Borges No 3, Arquiparque, Miraflores, Alges, Farmaceuticos, LDA iv 1499-013, Portugal SmithKline Beecham Australia Pty Ltd in liquidation Ordinary 1061 Mountain Highway, Boronia, VIC, 3155, Australia SmithKline Beecham Bangladesh Private Limited iv Ordinary 14, Topkhana Road, Segunbagicha, Dhaka 1000, Bangladesh SmithKline Beecham Cork Limited ii Ordinary Currabinny, Carrigaline, County Cork, Ireland SmithKline Beecham Export Limited Ordinary 980 Great West Road, Brentford, Middlesex, TW8 9GS, England SmithKline Beecham H Limited Non-cumulative non-redeemables: Ordinary 980 Great West Road, Brentford, Middlesex, TW8 9GS, England SmithKline Beecham Investments Limited Ordinary 980 Great West Road, Brentford, Middlesex, TW8 9GS, England SmithKline Beecham Manufacturing Limited ii Ordinary Currabinny, Carrigaline, County Cork, Ireland SmithKline Beecham SWG Limited Ordinary 980 Great West Road, Brentford, Middlesex, TW8 9GS, England SmithKline Beecham Biologicals US Partnership Partnership Interest Corporation Service Company, 251 Little Falls Drive, Wilmington, Delaware, 19808, United States SmithKline Beecham Egypt L. L. C. Quotas Amoun Street, El Salam City, Cairo, Egypt SmithKline Beecham Farma, S. A.
Ordinary Severo Ochoa, 2, Parque Tecnologico fide Madrid, Tres Cantos, Madrid, 28760, Spain SmithKline Beecham Holdings Australia Pty.
Limited Ordinary 1061 Mountain Highway, Boronia, VIC, 3155, Australia in liquidation SmithKline Beecham Inter-American Corporation iv Common Corporation Service Company, 251 Little Falls Drive, Wilmington, Delaware, 19808, United States SmithKline Beecham Limited Ordinary 6.25p 980 Great West Road, Brentford, Middlesex, TW8 9GS, England SmithKline Beecham Marketing and Technical Services Limited Ordinary 980 Great West Road, Brentford, Middlesex, TW8 9GS, England SmithKline Beecham Nominees Limited Ordinary 980 Great West Road, Brentford, Middlesex, TW8 9GS, England SmithKline Beecham Overseas Limited Ordinary 980 Great West Road, Brentford, Middlesex, TW8 9GS, England SmithKline Beecham Pension Plan Trustee Limited iv Ordinary 980 Great West Road, Brentford, Middlesex, TW8 9GS, England SmithKline Beecham Pension Trustees Limited iv Ordinary 980 Great West Road, Brentford, Middlesex, TW8 9GS, England SmithKline Beecham Pharma GmbH & Co KG Partnership Capital Prinzregentenplatz 9, Mnchen, 81675, Germany SmithKline Beecham Pharma Verwaltungs GmbH Ordinary Prinzregentenplatz 9, Mnchen, 81675, Germany SmithKline Beecham Pharmaceuticals Pty Limited iv vi Ordinary Flushing Meadows Building, The Campus, 57 Sloane Street, Bryanston 2021, South Africa SmithKline Beecham Pharmaceuticals Co. Common Corporation Service Company, 251 Little Falls Drive, Wilmington, Delaware, 19808, United States SmithKline Beecham Port Louis Limited vi Ordinary C o CIM Corporate Services Ltd, Les Cascades Building, Edith Cavell Street, Port Louis, Mauritius SmithKline Beecham Retirement Plan Nominees Pty Limited Ordinary 1061 Mountain Highway, Boronia, VIC, 3155, Australia in liquidation SmithKline Beecham Senior Executive Pension Plan Trustee Ordinary 980 Great West Road, Brentford, Middlesex, TW8 9GS, England Limited iv Stiefel Distributors Ireland Limited ii iv Ordinary Finisklin Business Park, Sligo, Ireland Stiefel Dominicana, S. R. L. iv vi Ordinary Ave. Lope fide Vega #29, Torre NovoCentro, Local 406, Santo Domingo, Dominican Republic Stiefel Farma, S. A.
Ordinary Severo Ochoa, 2, Parque Tecnologico fide Madrid, Tres Cantos, Madrid, 28760, Spain Stiefel GmbH & Co. KG Partnership Capital Industriestrasse 32-36, Bad Oldesloe, 23843, Germany 282 GSK Annual Report 2017 Other statutory disclosures continued Group companies continued Name Security Registered address Wholly owned subsidiaries continued Stiefel India Private Limited Equity 401-402, A, Wing, 4th Floor, Floral Deck Plaza, Opp Rolta Bhavan, Central MIDC Road, Mumbai, Andheri E, 400093, India Stiefel Laboratories Maidenhead Ltd Ordinary Eurasia Headquarters, Concorde Road, Maidenhead, Berkshire, SL6 4BY, England Stiefel Laboratories U. K. Ltd Ordinary Eurasia Headquarters, Concorde Road, Maidenhead, Berkshire, SL6 4BY, England Stiefel Laboratories Legacy Ireland Limited ii Ordinary Finisklin Business Park, Sligo, Ireland Stiefel Laboratories Limited iv Ordinary Eurasia Headquarters, Concorde Road, Maidenhead, Berkshire, SL6 4BY, England Stiefel Laboratories Pte Limited vi Ordinary 103 Gul Circle, 629589, Singapore Stiefel Laboratories Pty Ltd in liquidation Ordinary 1061 Mountain Highway, Boronia, VIC, 3155, Australia Stiefel Laboratories, Inc. Common Corporation Service Company, 251 Little Falls Drive, Wilmington, Delaware, 19808, United States Stiefel Maroc SARL Ordinary 275 Boulevard Zerktouni, Casablanca, Morocco Stiefel Research Australia Holdings Pty Ltd vi Ordinary 1061 Mountain Highway, Boronia, VIC, 3155, Australia Stiefel Research Australia Pty Ltd vi Ordinary 1061 Mountain Highway, Boronia, VIC, 3155, Australia Stiefel West Coast LLC LLC Interests Corporation Service Company, 251 Little Falls Drive, Wilmington, Delaware, 19808, United States Strebor Inc. Common Corporation Service Company, 251 Little Falls Drive, Wilmington, Delaware, 19808, United States Tempero Pharmaceuticals, Inc. Series A Preference: Corporation Service Company, 251 Little Falls Drive, Wilmington, Series B Preference: Common Delaware, 19808, United States The Sydney Ross Co. iv Ordinary Corporation Service Company, Princeton South Corporate Center, Suite 160, 100 Charles Ewing Blvd, Ewing, New Jersey, 08628, United States The Wellcome Foundation Limited Ordinary 980 Great West Road, Brentford, Middlesex, TW8 9GS, England UCB Pharma Asia Pacific Sdn Bhd iv Ordinary Level 8, Symphony House, Pusat Dagangan Dana 1, Jalan PJU 1A 46, Petaling Jaya, Selangor Darul Ehsan, 47301, Malaysia Wellcome Consumer Healthcare Limited iv Ordinary 980 Great West Road, Brentford, Middlesex, TW8 9GS, England Wellcome Consumer Products Limited iv Ordinary 980 Great West Road, Brentford, Middlesex, TW8 9GS, England Wellcome Developments Pty Ltd iv vi Ordinary 1061 Mountain Highway, Boronia, VIC, 3155, Australia Wellcome Limited Ordinary 980 Great West Road, Brentford, Middlesex, TW8 9GS, England Wellcome Operations Pty Ltd iv vi Ordinary 1061 Mountain Highway, Boronia, VIC, 3155, Australia Effective % Name Security Ownership Registered address Subsidiaries where the effective interest is less than 100% Amoun Pharmaceutical Industries Co. S. A. E. New Monetary Shares 90.7 El Salam City 11491, PO Box 3001, Cairo, Egypt 99.5% Beecham Enterprises Inc. iv Common 55.9 Corporation Service Company, 251 Little Falls Drive, Wilmington, Delaware, 19808, United States Block Drug Company, Inc. Common 63.5 Corporation Service Company, Princeton South Corporate Center, Suite 160, 100 Charles Ewing Blvd, Ewing, New Jersey, 08628, United States Block Drug Corporation iv Common 63.5 Corporation Service Company, Princeton South Corporate Center, Suite 160, 100 Charles Ewing Blvd, Ewing, New Jersey, 08628, United States British Pharma Group Limited i Captial 50% 50 980 Great West Road, Brentford, Middlesex, TW8 9GS, England fide Micln a. s. Ordinary 63.5 Priemyselny Park Gena, Ul.
E. Sachsa 4-6, 934 01, Levice, Slovakia Duncan Consumer Healthcare Philippines Inc Common 63.5 2266 Don Chino Roces Avenue, Makati City, Philippines Duncan Pharmaceuticals Philippines Inc. Common 91.5 2266 Don Chino Roces Avenue, Makati City, Philippines Ex-Lax, Inc. Common 63.5 The Prentice Hall Corporation System, Puerto Rico, Inc. c o Fast Solutions, LLC, Citi Tower, 252 Ponce fide Leon Avenue, Floor 20, San Juan, 00918, Puerto Rico Galvani Bioelectronics Inc. Common 55 Corporation Service Company, 251 Little Falls Drive, Wilmington, Delaware, 19808, United States Galvani Bioelectronics Limited A Ordinary: 55 980 Great West Road, Brentford, Middlesex, TW8 9GS, England B Ordinary 0% Glaxo Saudi Arabia Limited Ordinary 75 PO Box 22617, Area No 73 to 156, Warehouse City, First Stage Al Khomrah, Jeddah 21416, Saudi Arabia 283 GSK Annual Report 2017 Strategic report Governance and remuneration Financial statements Investor information Group companies continued Effective % Name Security Ownership Registered address Subsidiaries where the effective interest is less than 100% continued Glaxo Wellcome Ceylon Limited Ordinary: 63.3 121 Galle Road, Kaldemulla, Moratuwa, Sri Lanka Ordinary B GlaxoSmithKline Tianjin Co. Ltd Ordinary 90% 90 No.
65, the Fifth Avenue, Tai Feng Industrial Park, Tianjin Economic and Technolog, Tianjin, 300457, China GlaxoSmithKline Algrie S. P. A.
Ordinary 99.99 Zone Industrielle Est, Boudouaou, Wilaya fide Boumerdes, Algeria GlaxoSmithKline Bangladesh Limited Ordinary 82% 82 Fouzderhat Industrial Area, Dhaka Trunk Road, North Kattali, Chittagong 4217, Bangladesh GlaxoSmithKline Brasil Produtos para Consumo e Saude Ltda Quotas 63.5 66 BL1 302, Vitor Civita Street, Barra Tijuca, Rio fide Janeiro, 22775-044, Brazil GlaxoSmithKline Consumer Healthcare China Co. Ltd Ordinary 63.5 Rooms 01A, 06B-09, 23F, The Headquarters Building, No.
168 Tibet Road M, Shanghai, 200001, China GlaxoSmithKline Consumer Healthcare Hong Kong Limited Ordinary 63.5 Units 2201, 2214 and 23 F, Tower 6, The Gateway, 9 Canton Road, Harbour City, Tsimshatsui, Kowloon, Hong Kong GlaxoSmithKline Consumer Healthcare Ireland Limited ii Ordinary 63.5 12 Riverwalk Citywest Business Campus, Dublin, 24, Ireland GlaxoSmithKline Consumer Healthcare Overseas Limited Ordinary 63.5 980 Great West Road, Brentford, Middlesex, TW8 9GS, England GlaxoSmithKline Consumer Healthcare Thailand Limited Ordinary 63.5 13th Floor, Unit 13.05 and 13.06 Wave Place, 55 Wireless Road, Lumpini, Pathumwan, Bangkok, 10330, Thailand GlaxoSmithKline Consumer Healthcare UK IP Limited Ordinary 63.5 980 Great West Road, Brentford, Middlesex, TW8 9GS, England GlaxoSmithKline Consumer Healthcare UK Trading Limited Ordinary 63.5 980 Great West Road, Brentford, Middlesex, TW8 9GS, England GlaxoSmithKline Consumer Healthcare US IP LLC LLC Interests 63.5 Corporation Service Company, 251 Little Falls Drive, Wilmington, Delaware, 19808, United States GlaxoSmithKline Consumer Healthcare A S Ordinary 63.5 Nykaer 68, Brondby, DK-2605, Denmark GlaxoSmithKline Consumer Healthcare AB vii Ordinary 63.5 Nykaer 68, DK-2605, Brondby, Denmark GlaxoSmithKline Consumer Healthcare Australia Pty Ltd Ordinary 63.5 82 Hughes Avenue, Ermington, NSW, 2115, Australia GlaxoSmithKline Consumer Healthcare B. V. Ordinary 63.5 Huis ter Heideweg 62, 3705 LZ, Zeist, Netherlands GlaxoSmithKline Consumer Healthcare Colombia SAS Ordinary 63.5 Avenida El Dorado, #69B-45 Piso 9, Bogota, Colombia GlaxoSmithKline Consumer Healthcare Czech Republic s. r. o.
Ordinary 63.5 Hvezdova 1734 2c, Prague, 4 140 00, Czech Republic GlaxoSmithKline Consumer Healthcare Finance Limited Ordinary 63.5 980 Great West Road, Brentford, Middlesex, TW8 9GS, England GlaxoSmithKline Consumer Healthcare Finance No.
2 Limited Ordinary 63.5 980 Great West Road, Brentford, Middlesex, TW8 9GS, England GlaxoSmithKline Consumer Healthcare Finland Oy Ordinary 63.5 Piispansilta 9A, Fin-02230, Espoo, Finland GlaxoSmithKline Consumer Healthcare GmbH Ordinary 63.5 Wagenseilgasse 3, Euro Plaza, Gebude I, 4.
Stock, Vienna, A-1120, Austria GlaxoSmithKline Consumer Healthcare GmbH & Co. KG Partnership Capital 63.5 Barthstr.
4, Mnchen, 80339, Germany GlaxoSmithKline Consumer Healthcare Greece Societe Ordinary 63.5 274 Kifissias Avenue Halandri, Athens, 152 32, Greece Anonyme GlaxoSmithKline Consumer Healthcare Holdings US LLC LLC Interests 63.5 Corporation Service Company, 251 Little Falls Drive, Wilmington, Delaware, 19808, United States GlaxoSmithKline Consumer Healthcare Holdings Limited Ordinary A: 63.5 980 Great West Road, Brentford, Middlesex, TW8 9GS, England Ordinary B 0% GlaxoSmithKline Consumer Healthcare Inc. Common 63.5 7333 Mississauga Road North, Mississagua, ON, L5N 6L4, Canada GlaxoSmithKline Consumer Healthcare Investments Ireland Ordinary 63.5 Knockbrack, Dungarvan, Co Waterford, X35 RY76, Ireland No 3 Limited ii v GlaxoSmithKline Consumer Healthcare Investments Ireland Ordinary 63.5 Knockbrack, Dungarvan, Co Waterford, X35 RY76, Ireland No.
2 Unlimited Company ii iv v GlaxoSmithKline Consumer Healthcare Japan K. K. Ordinary 63.5 1-8-1 Asasaka Minato-ku, Tokyo, Japan GlaxoSmithKline Consumer Healthcare Korea Co. Ltd.
Ordinary 63.5 9F LS Yongsan Tower, 92, Hangang-daero, Yongsan-gu, Seoul, 140-702, Republic of Korea GlaxoSmithKline Consumer Healthcare L. L. C. LLC Interests 63.5 Corporation Service Company, 2595 Interstate Drive Suite 103, Harrisburg, Pennsylvania, 17110, United States GlaxoSmithKline Consumer Healthcare Limited Equity 72.5% 72.5 Patiala Road, Nabha 147201, Dist Patiala, Punjab, India GlaxoSmithKline Consumer Healthcare Mexico, Ordinary 63.5 Calzada Mexico-Xochimilco 4900, Colonia San Lorenzo Huipulco, S. fide R. L. fide C. V. Delegacion Tlalpan, Mexico, D. F. 14370, Mexico GlaxoSmithKline Consumer Healthcare New Zealand Limited Ordinary 63.5 Level 11, Zurich House, 21 Queen Street, Auckland, 1010, New Zealand GlaxoSmithKline Consumer Healthcare Norway AS Ordinary 63.5 Klaus Torgrds vei 3, Oslo, NO-0372, Norway GlaxoSmithKline Consumer Healthcare Pakistan Limited Ordinary 82.6% 52.4 The Sykes Building, 35 Dockyard Road, West Wharf, Karachi, 74000, Pakistan GlaxoSmithKline Consumer Healthcare Philippines Inc Common 63.5 2266 Don Chino Roces Avenue, Makati City, Philippines GlaxoSmithKline Consumer Healthcare Pte.
Ordinary 63.5 23 Rochester Park, 139234, Singapore GlaxoSmithKline Consumer Healthcare S. A.
Ordinary 63.5 Site Apollo, Avenue Pascal 2-4-6, Wavre, 1300, Belgium GlaxoSmithKline Consumer Healthcare S. A.
Ordinary 63.5 Severo Ochoa, 2, Parque Tecnologico fide Madrid, Tres Cantos, Madrid, 28760, Spain 284 GSK Annual Report 2017 Other statutory disclosures continued Group companies continued Effective % Name Security Ownership Registered address Subsidiaries where the effective interest is less than 100% continued GlaxoSmithKline Consumer Healthcare S. p. A.
Ordinary 63.5 Via Zambeletti snc, Baranzate, Milan, 20021, Italy GlaxoSmithKline Consumer Healthcare Sdn.
Ordinary 63.5 Lot 89, Jalan Enggang, Ampang Ulu Kelang Industrial Estate, Selangor, 54200, Malaysia GlaxoSmithKline Consumer Healthcare Slovakia s. r. o.
Ownership interest 63.5 Galvaniho 7 A, Bratislava, 821 04, Slovakia GlaxoSmithKline Consumer Healthcare South Africa Pty Ltd Ordinary 63.5 Flushing Meadows Building, The Campus, 57 Sloane Street, Bryanston 2021, South Africa GlaxoSmithKline Consumer Healthcare Sp.
Rzymowskiego 53, Warsaw, 02-697, Poland GlaxoSmithKline Consumer Healthcare Sri Lanka Ordinary 63.5 980 Great West Road, Brentford, Middlesex, TW8 9GS, England Holdings Limited GlaxoSmithKline Consumer Healthcare SRL Ordinary 63.5 1-5 Costache Negri Street, Opera Center One, 6th floor Zone 2, District 5, Bucharest, Romania GlaxoSmithKline Consumer Healthcare Vietnam Charter Capital 63.5 Floor 16, Metropolitan, 235 Dong Khoi, Ben Nghe Ward, District 1, Company Limited Ho Chi Minh City, Viet Nam GlaxoSmithKline Consumer Healthcare, L. P. Partnership Interest 55.9% 55.9 Corporation Service Company, 251 Little Falls Drive, Wilmington, Delaware, 19808, United States GlaxoSmithKline Consumer Healthcare, Produtos para Ordinary Quota 63.5 Rua Dr Antonio Loureiro Borges No 3, Arquiparque, Miraflores, Alges, a Saude e Higiene, Lda 1499-013, Portugal GlaxoSmithKline Consumer Nigeria plc iii Ordinary 46.4% 46.4 1 Industrial Avenue, Ilupeju, Ikeja, Lagos, PM B 21218, Nigeria GlaxoSmithKline Consumer Private Limited Equity 63.5 Patiala Road, Nabha 147201, Dist Patiala, Punjab, India GlaxoSmithKline Consumer Trading Services Limited Ordinary 63.5 980 Great West Road, Brentford, Middlesex, TW8 9GS, England GlaxoSmithKline Costa Rica S. A.
Ordinary 63.5 San Jose 300 Este fide la Rotonda Betania, Carretera a Sabanilla, Costa Rica GlaxoSmithKline Dungarvan Limited ii Ordinary 63.5 Knockbrack, Dungarvan, Co Waterford, X35 RY76, Ireland GlaxoSmithKline Healthcare AO Ordinary 63.5 Presnenskaya nab 10, Moscow, 123112 GlaxoSmithKline Healthcare GmbH Ordinary 63.5 Barthstr.
4, Mnchen, 80339, Germany GlaxoSmithKline Healthcare Ukraine O. O. O.
Ownership interest 63.5 Pavla Tychyny avenue, 1-V, Kiev, 02152, Ukraine GlaxoSmithKline Limited Ordinary 63.5 Likoni Road, PO Box 78392, Nairobi, Kenya GlaxoSmithKline OTC PVT.
Limited Ordinary 63.5 The Sykes Building, 35 Dockyard Road, West Wharf, Karachi, 74000, Pakistan GlaxoSmithKline Pakistan Limited Ordinary 82.6% 82.6 The Sykes Building, 35 Dockyard Road, West Wharf, Karachi, 74000, Pakistan GlaxoSmithKline Panama S. A.
Ordinary 63.5 Panama City, Republic of Panama, Panama GlaxoSmithKline Paraguay S. A.
Ordinary 63.5 Oficial Gilberto Aranda 333, Planta Alta casi Salvador del Mundo, Asuncion, Paraguay GlaxoSmithKline Pharmaceuticals Limited Equity 75% 75 252 Dr Annie Besant Road, Mumbai, 400030, India GlaxoSmithKline Philippines Inc Common 91.5 2266 Chino Roces Avenue, Makati City, Philippines GlaxoSmithKline S. A. E. Ordinary 91.2% 91.2 Boomerang Office Building Land No.
46, Zone J 1st District, Town Center 5th Tagammoe, New Cairo City, Egypt GlaxoSmithKline Sante Grand Public SAS Ordinary 63.5 23 rue Franois Jacob, 92500, Rueil-Malmaison, France GlaxoSmithKline Tuketici Sagligi Anonim Sirketi Nominative 63.5 Bykdere Caddesi No.
Levent, Istanbul, 34394, Turkey  Hungary Limited Liability Company Membership 63.5 H-1124, Csorsz utca 43, Budapest, Hungary GSK CH Kazakhstan LLP Charter Capital 63.5 32 A Manasa Str.
Bostandyk District, Almaty, 050008, Kazakhstan GSK Consumer Health, Inc. Common 63.5 Corporation Service Company, 251 Little Falls Drive, Wilmington, Delaware, 19808, United States GSK Consumer Healthcare Israel Ltd iv Ordinary 63.5 25 Basel Street, Petech Tikva 49510, Israel GSK Consumer Healthcare Schweiz AG Ordinary 63.5 Suurstoffi 14, Rotkreuz, 6343, Switzerland GSK Consumer Healthcare Services, Inc. Common 63.5 Corporation Service Company, 251 Little Falls Drive, Wilmington, Delaware, 19808, United States GSK Consumer Healthcare Singapore Pte.
Ordinary 63.5 23 Rochester Park, 139234, Singapore GSK-Gebro Consumer Healthcare GmbH Ordinary 38.1 Bahnhofbichl 1, 6391 Fieberbrunn, Kitzbhel, Austria Iodosan S. p. A.
Ordinary 63.5 Via Zambeletti snc, Baranzate, Milan, 20021, Italy Kuhs GmbH Ordinary 63.5 Barthstr.
4, Mnchen, 80339, Germany Laboratorios ViiV Healthcare, S. L. Ordinary 78.3 Severo Ochoa, 2, Parque Tecnologico fide Madrid, Tres Cantos, Madrid, 28760, Spain Modern Pharma Trading Company L. L. C. Quotas 98.2% 98.2 Amoun Street, PO Box 3001, El Salam City, Cairo, 11491, Egypt N. C. H. Nutrition Consumer Health Ltd vi Ordinary 63.5 14 Hamephalsim St, Petach Tikva, Israel Novartis Consumer Health Australasia Pty Ltd iv vi Ordinary: 63.5 82 Hughes Avenue, Ermington, NSW, 2115, Australia Redeemable Preference Novartis Consumer Health GmbH Ordinary 63.5 Barthstr.
4, Mnchen, 80339, Germany 285 GSK Annual Report 2017 Strategic report Governance and remuneration Financial statements Investor information Group companies continued Effective % Name Security Ownership Registered address Subsidiaries where the effective interest is less than 100% continued Novartis Consumer Health S. A.
Ordinary 63.5 Route fide I'Etraz 2, 1197 Prangins, Switzerland Novartis Consumer Health UK Limited Ordinary 63.5 Park View, Riverside Way, Watchmoor Park, Camberley, Surrey, GU15 3YL, England P. T. SmithKline Beecham Pharmaceuticals A Shares: 99 Jl.
III DD 2,3, 4, Kawasan Industri Pulogadung, B Shares 0% Jakarta, 13930, Indonesia P. T. Sterling Products Indonesia A shares: 63.5 Graha Paramita Building, 5th F, Jalan Denpasar Raya Blok D-2, Jakarta, B Shares 12940, Indonesia Panadol GmbH Ordinary 63.5 Barthstr.
4, Mnchen, 80339, Germany PHIVCO Jersey II Limited iv v Ordinary 78.3 13 Castle Street, St. Helier, JE4 5UT, Jersey PHIVCO Jersey Limited iv v Ordinary 78.3 13 Castle Street, St. Helier, JE4 5UT, Jersey PHIVCO UK II Limited Ordinary 78.3 980 Great West Road, Brentford, Middlesex, TW8 9GS, England PHIVCO UK Limited Ordinary 78.3 980 Great West Road, Brentford, Middlesex, TW8 9GS, England PHIVCO-1 LLC LLC Interests 78.3 Corporation Service Company, 251 Little Falls Drive, Wilmington, Delaware, 19808, United States PHIVCO-2 LLC LLC Interests 78.3 Corporation Service Company, 251 Little Falls Drive, Wilmington, Delaware, 19808, United States PT Glaxo Wellcome Indonesia A Shares: 95 Jl Pulobuaran Raya Kav III DD, Kawasan Industri Pulogadung, Timur, B Shares 0% Jakarta, 13930, Indonesia PT GSK Consumer Healthcare Indonesia Ordinary 63.5 Graha Paramita 3B Floor, Jl.
Denpasar Raya Blok D-2, Kuningan, Jakarta, 12940, Indonesia PT.
Bina Dentalindo in liquidation Ordinary 63.5 Gedung Graha Ganesha Lantai 3, Jl Raya Bekasi Km 17, No5, Jakarta Timur 13930, Indonesia Shionogi-ViiV Healthcare LLC iv Common Interests 78.3 Corporation Service Company, 251 Little Falls Drive, Wilmington, Delaware, 19808, United States Sino-American Tianjin Smith Kline & French Laboratories Ltd Ordinary 55% 34.9 Cheng Lin Zhuang Industrial Zone, Dong Li District, Tianjin, 300163, China SmithKline Beecham Private Limited Ordinary 99.6% 63.3 World Trade Center, Level 34, West Tower, Echelon Square, Colombo 1, Sri Lanka SmithKline Beecham Research Limited Ordinary 63.5 980 Great West Road, Brentford, Middlesex, TW8 9GS, England SmithKline Beecham S. A.
Ordinary 63.5 Ctra fide Ajalvir Km 2.500, Alcala fide Henares, Madrid, 28806, Spain SmithKline Beecham-Biomed O. O. O.
Moscow, 121614, Russian Federation Stafford-Miller Ireland Limited ii Ordinary 63.5 Clocherane, Youghal Road, Dungarvan, Co. Waterford, Ireland Stafford-Miller Limited Ordinary: 63.5 980 Great West Road, Brentford, Middlesex, TW8 9GS, England Non-Cumulative Non Redeemable Preference Sterling Drug Malaya Sdn Berhad Ordinary 63.5 Lot 89, Jalan Enggang, Ampang Ulu Kelang Industrial Estate, Selangor, 54200, Malaysia Sterling Products International, Incorporated iv Common 63.5 Corporation Service Company, 251 Little Falls Drive, Wilmington, Delaware, 19808, United States Stiefel Consumer Healthcare UK Limited Ordinary 63.5 980 Great West Road, Brentford, Middlesex, TW8 9GS, England Stiefel Egypt LLC iv Quota 99% 99 3 Amoun Street, El Salam City, Cairo, Egypt Stiefel Laboratories Ireland Limited ii Ordinary 63.5 Finisklin Business Park, County Sligo, Ireland ViiV Healthcare South Africa Proprietary Limited Ordinary 78.3 Flushing Meadows Building, The Campus, 57 Sloane Street, Bryanston 2021, South Africa ViiV HealthCare BV Ordinary 78.3 Huis ter Heideweg 62, 3705 LZ, Zeist, Netherlands ViiV Healthcare Company Common 78.3 Corporation Service Company, 251 Little Falls Drive, Wilmington, Delaware, 19808, United States ViiV Healthcare Finance 1 Limited Ordinary 78.3 980 Great West Road, Brentford, Middlesex, TW8 9GS, England ViiV Healthcare Finance 2 Limited Ordinary 78.3 980 Great West Road, Brentford, Middlesex, TW8 9GS, England ViiV Healthcare Finance Limited Ordinary: 78.3 980 Great West Road, Brentford, Middlesex, TW8 9GS, England Redeemable Preference ViiV Healthcare GmbH Ordinary 78.3 Prinzregentenplatz 9, Mnchen, 81675, Germany ViiV Healthcare GmbH Ordinary 78.3 Talstrasse 3-5, 3053 Muenchenbuchsee, Switzerland ViiV Healthcare Hong Kong Limited Ordinary 78.3 23 F Tower 6, The Gateway, 9 Canton Road, Harbour City, Tsimshatsui, Kowloon, Hong Kong ViiV Healthcare Kabushiki Kaisha Ordinary 78.3 1-8-1 Asasaka Minato-ku, Tokyo, Japan ViiV Healthcare Limited Class A Shares, Deferred: 78.3 980 Great West Road, Brentford, Middlesex, TW8 9GS, England Class B Shares 0% : Class C Shares 0% : Class D1 0% : Class D2 0% : Class E 5% Cumulative Preference 0% 286 GSK Annual Report 2017 Other statutory disclosures continued Group companies continued Effective % Name Security Ownership Registered address Subsidiaries where the effective interest is less than 100% continued ViiV Healthcare Overseas Limited Ordinary 78.3 980 Great West Road, Brentford, Middlesex, TW8 9GS, England ViiV Healthcare Pty Ltd Ordinary 78.3 1061 Mountain Highway, Boronia, VIC, 3155, Australia ViiV Healthcare Puerto Rico, LLC LLC Interests 78.3 Centro International fide Mercadeo, 90 carr.
165 Torre 2, Suite 800, Guaynabo, 00968, Puerto Rico ViiV Healthcare S. r. l. Quota 78.3 Via Alessandro Fleming 2, Verona, 37135, Italy ViiV Healthcare SAS Ordinary 78.3 23 rue Franois Jacob, 92500, Rueil-Malmaison, France ViiV Healthcare sprl Ordinary 78.3 Site Apollo, Avenue Pascal 2-4-6, Wavre, 1300, Belgium ViiV Healthcare Trading LLC iv Participation Interest 78.3 Krylatskaya str.
Moscow, 121614, Russian Federation ViiV Healthcare Trading Services UK Limited Ordinary 78.3 980 Great West Road, Brentford, Middlesex, TW8 9GS, England ViiV Healthcare UK No.
2 Limited v Ordinary 78.3 13 Castle Street, St. Helier, JE4 5UT, Jersey ViiV Healthcare UK No.
3 Limited Ordinary 78.3 980 Great West Road, Brentford, Middlesex, TW8 9GS, England ViiV Healthcare UK No.
4 Limited Ordinary 78.3 980 Great West Road, Brentford, Middlesex, TW8 9GS, England ViiV Healthcare UK No.
5 Limited Ordinary 78.3 980 Great West Road, Brentford, Middlesex, TW8 9GS, England ViiV Healthcare UK Limited Ordinary 78.3 980 Great West Road, Brentford, Middlesex, TW8 9GS, England ViiV Healthcare ULC Common 78.3 3500 855-2nd Street SW, Calgary, AB, T2P 4J8, Canada ViiV Healthcare Venture LLC LLC Interests 78.3 Corporation Service Company, 251 Little Falls Drive, Wilmington, Delaware, 19808, United States ViiVHIV Healthcare Unipessoal Lda Quota 78.3 Rua Dr Antonio Loureiro Borges No 3, Arquiparque, Miraflores, Alges, 1499-013, Portugal Winster Pharmaceuticals Limited iv Ordinary 46.4 2A Association Avenue, Ilupeju Industrial Estate, Lagos, PO Box 3199, Nigeria Zhejiang Tianyuan Bio-Pharmaceutical Co. Ltd.
56, Tian He Road, Yuhang Economic Development Zone, Hangzhou, Zhejiang Province, China Associates Apollo Therapeutics LLP Partnership Interest 25% 25 Calci Medica Inc. Series A and Junior 43.3 Preferred 33.9% GlaxoSmithKline Landholding Company, Inc. Common 40% 40 Index Ventures Life VI Jersey LP Partnership Interest 25% 25 Innoviva, Inc. Common 31.4% 31.4 Japan Vaccine Distribution Co. Ltd Ordinary 50% 50 Kurma Biofund II, FCPR Partnership Interest 32% 32 Longwood Founders Fund LP Partnership Interest 28% 28 Medicxi Ventures I LP Partnership Interest 26.2% 26.2 Joint Ventures Chiron Panacea Vaccines Private Limited in liquidation 50 708 718, 7th Floor, A Wing, Sagar Tech Plaza, Saki Naka, Andheri East, Mumbai, Maharashtra, 400072, India Japan Vaccine Co. Ltd. 50 6 Yonbancho, Chiyoda-ku, Tokyo, Japan Qualivax Pte.
Limited 50 80 Robinson Road, #02-00, 068898, Singapore Qura Therapeutics, LLC 50 Corporation Service Company, 251 Little Falls Drive, Wilmington, Delaware, 19808, United States Key i Directly owned by GlaxoSmithKline plc.
ii Exempt from the provisions of section 3 47 and 348 of the Companies Act 2014 v Tax resident in the UK.
Ireland, in accordance with the exemptions noted in Section 357 of that Act.
vi Entity expected to be disposed of or removed.
iii Consolidated as a subsidiary in accordance with section 1162 4 a of the vii Incorporated in Sweden.
Companies Act 2006 on the grounds of dominant influence.
287 GSK Annual Report 2017 Strategic report Governance and remuneration Financial statements Investor information Glossary of terms Terms used in the Annual Report US equivalent or brief description Accelerated capital allowances Tax allowance in excess of depreciation arising from the purchase of fixed assets that delay the charging and payment of tax.
The equivalent of tax depreciation.
American Depositary Receipt ADR Receipt evidencing title to an ADS.
Each GSK ADR represents two Ordinary Shares.
American Depositary Shares ADS Listed on the New York Stock Exchange: represents two Ordinary Shares.
Basic earnings per share Basic income per share.
Called up share capital Ordinary Shares, issued and fully paid.
CER growth Growth at constant exchange rates.
Currency swap An exchange of two currencies, coupled with a subsequent re-exchange of those currencies, at agreed exchange rates and dates.
Defined benefit plan Pension plan with specific employee benefits, often called final salary scheme.
Defined contribution plan Pension plan with specific contributions and a level of pension dependent upon the growth of the pension fund.
Derivative financial instrument A financial instrument that derives its value from the price or rate of some underlying item.
Diluted earnings per share Diluted income per share.
Employee Share Ownership Plan Trusts Trusts established by the Group to satisfy share-based employee incentive plans.
Equity Shareholders funds Shareholders equity.
Freehold Ownership with absolute rights in perpetuity.
The Group GlaxoSmithKline plc and its subsidiary undertakings.
GSK GlaxoSmithKline plc and its subsidiary undertakings.
Hedging The reduction of risk, normally in relation to foreign currency or interest rate movements, by making off-setting commitments.
Intangible fixed assets Assets without physical substance, such as computer software, brands, licences, patents, know-how and marketing rights purchased from outside parties.
Novartis transaction The three-part inter-conditional transaction with Novartis AG involving the Consumer Healthcare, Vaccines and Oncology businesses completed on 2 March 2015.
Ordinary Share A fully paid up ordinary share in the capital of the company.
Profit attributable to shareholders Net income.
Share capital Ordinary Shares, capital stock or common stock issued and fully paid.
Share premium account Additional paid-up capital or paid-in surplus not distributable.
Shares in issue The number of shares outstanding.
Subsidiary An entity in which GSK exercises control.
UK Corporate Governance Code As required by the UK Listing Authority, the company has disclosed in the Annual Report how it has applied the best practice corporate governance provisions of the Financial Reporting Councils UK Corporate Governance Code.
